115 related articles for article (PubMed ID: 483231)
1. The Anturane reinfarction trial.
Sherry S
Thromb Haemost; 1979 Feb; 41(1):197-201. PubMed ID: 483231
[No Abstract] [Full Text] [Related]
2. The FDA's critique of the anturane reinfarction trial.
Temple R; Pledger GW
N Engl J Med; 1980 Dec; 303(25):1488-92. PubMed ID: 7432418
[No Abstract] [Full Text] [Related]
3. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
Anturane Reinfarction Trial Research Group
N Engl J Med; 1978 Feb; 298(6):289-95. PubMed ID: 340942
[TBL] [Abstract][Full Text] [Related]
4. The anturane reinfarction trial.
Shepard DS; Zeckhauser RJ
N Engl J Med; 1980 Jul; 303(1):49. PubMed ID: 6990265
[No Abstract] [Full Text] [Related]
5. The anturane reinfarction trial.
Schiff AA
N Engl J Med; 1980 Jul; 303(1):48. PubMed ID: 6990263
[No Abstract] [Full Text] [Related]
6. Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.
Latour JG; Theroux P; Bourassa MG
Am J Cardiol; 1982 Nov; 50(5):938-44. PubMed ID: 6753559
[TBL] [Abstract][Full Text] [Related]
7. The anturane reinfarction trial.
Rothlin M
N Engl J Med; 1980 Jul; 303(1):48. PubMed ID: 6103510
[No Abstract] [Full Text] [Related]
8. Anturane reinfarction trial.
Meier P
N Engl J Med; 1981 Mar; 304(12):730. PubMed ID: 7464868
[No Abstract] [Full Text] [Related]
9. The anturane reinfarction trial.
Sherry S
Circulation; 1980 Dec; 62(6 Pt 2):V73-8. PubMed ID: 7438382
[TBL] [Abstract][Full Text] [Related]
10. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
Bolte HD
MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
[No Abstract] [Full Text] [Related]
11. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
Rühle H
Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
[No Abstract] [Full Text] [Related]
12. The Anturane Reinfarction Trial: reevaluation of outcome.
N Engl J Med; 1982 Apr; 306(16):1005-8. PubMed ID: 7038496
[No Abstract] [Full Text] [Related]
13. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
[No Abstract] [Full Text] [Related]
14. The anturane reinfarction trial.
Boelaert J; Van Eeghem P; Daneels R; Meyrier A; Sraer JD; Kourilsky O; Dard S; El Nahos M
N Engl J Med; 1980 Jul; 303(1):49. PubMed ID: 6990264
[No Abstract] [Full Text] [Related]
15. [Sulfinpyrazone in the prevention of sudden death after myocardial infarction (author's transl)].
Sherry S
MMW Munch Med Wochenschr; 1980 Apr; 122(14):517-24. PubMed ID: 6769032
[TBL] [Abstract][Full Text] [Related]
16. The anturane reinfarction trial.
Cowan JC; Williams EM
N Engl J Med; 1980 Jul; 303(1):48-9. PubMed ID: 7374739
[No Abstract] [Full Text] [Related]
17. [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)].
Gülker H; Bender F; Thale J; Heuer H; Kristek J; Dorsel T; Pierchalla P
Z Kardiol; 1980 Nov; 69(11):751-6. PubMed ID: 7467658
[TBL] [Abstract][Full Text] [Related]
18. Post-infarct sudden deaths curbed by sulfinpyrazone.
Hosp Pract; 1980 Mar; 15(3):139-40. PubMed ID: 7399468
[No Abstract] [Full Text] [Related]
19. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
20. Reduction in the severity of myocardial infarction by sulfinpyrazone.
Innes IR; Weisman H
Am Heart J; 1981 Aug; 102(2):153-7. PubMed ID: 7258086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
